The program times are listed in Central European Time (CEST)
ORAL GLP-1RA: NOVEL BUT NOT NEW - Industry Symposium Supported by Novo Nordisk
Session description - Discuss how semaglutide can be delivered as an oral formulation and drive early GLP-1RA initiation while also benefiting individuals with longstanding type 2 diabetes. Large peptide molecules generally require injection for medication delivery. This session will introduce you to the technology that facilitates semaglutide to be delivered as a simple, daily oral tablet. Explore frequently asked questions from people with diabetes and learn where an oral GLP-1RA fits into their daily routine.
MiniMed™ 780G System: Improving Clinical Outcomes while Reducing Diabetes Management Burden - Industry Symposium Supported by Medtronic
Session description - Innovation of technology in type 1 diabetes has transformed the therapy and significantly improved both clinical and patient related outcomes. In this symposium, the most recent data on the transformation brought by the introduction of automated insulin delivery system - the MiniMed™ 780G system-, on goals obtainment in real world will be presented. The opportunities brought by these to onboard a wider population of people with diabetes, even those without extensive exposure to technology, will be demonstrated. Further innovation toward extending infusion sets wear to 7 days, and its performance with automated insulin delivery system will be presented, as an additional step toward improving users’ experience. A look toward the future innovation will be offered by the leaders of Medtronic R&D
Novel detachable insulin patch pump MEDISAFE WITH - Industry Symposium Supported by Terumo Corporation
Session description -Terumo is a medical device company offering diverse medical devices and services globally. This year is Terumo’s 100th anniversary. Terumo started diabetes business in 1982 and continuously developed various blood glucose meters and needles for Pen injectors. Furthermore in 2018, we launched an insulin patch pump in Japanese market to meet the various needs of patients and medical professionals. In this symposium, we will introduce Japan’s first Novel detachable insulin patch pump “MEDISAFE WITH”. 3 speakers will give their presentations on the following topics:
“Current status and issues of insulin pumps in Japan - Clinical experience of MEDISAFE WITH”
“Description of a Novel Patch Pump for Insulin Delivery and Comparative Accuracy Evaluation” ,
“Use of technology for treatment of diabetes in Italy ‘state of the art’”
Starting this unforgettable memorial year, Terumo is proud to stand alongside diabetes patients, providing the services to support a happier life.
We hope all of you enjoy this symposium.
Evolving Observational and Real World Data Around Sensor-Based CGM Across the Diabetes Treatment Spectrum - Industry Symposium Supported by Abbott Diabetes Care
Session description - Using international authorities on diabetes management and technology as faculty, this activity will focus on emerging digital, real time-, and sensor patch-based technologies for continuous monitoring of glucose levels, to improve drug interventions for persons with diabetes, minimize risks of hypoglycemia, maximize time in target range for blood glucose, and to optimize treatment interventions and drug titration and selection. The faculty will discuss the Intersection of flash glucose monitoring technology and real world application, and the Implications for adopting CGM in the Covid era and beyond.
Personalized Insulin Delivery Using Smart Pens - Industry Symposium Supported by Novo Nordisk
Session description - The Novo Nordisk symposium at ATTD 2021 entitled “Personalized Insulin Delivery Using Smart Pens” aims at exploring the innovations and advancements in personalized insulin delivery using smart pens. The symposium will talk about the latest clinical data available for smart pens, how to visualize injection data and interpret the insulin delivery data in clinical practice besides discussing the health economics data supporting the use of smart pens. Richard Bergenstal, a distinguished endocrinologist will be chairing the symposium and will have other esteemed faculty like Peter Adolfsson, Lena Landstedt-Hallin and Johan Jendle as speakers for this symposium. The event will also include a live Q&A session, providing attendees with the opportunity to interact with these expert faculty.